References
- Barker-Haliski M.L., Friedman D., French J.A., White H.S.:
Disease modification in epilepsy: from animal models to clinical applications . Drugs, 2015, 75: 749–767. - Baulac M., de Boer H., Elger Ch., Glynn M., Kalviainen R., Little A. et al.:Epilepsy priorities in Europe: a report of the ILAE-IBE Epilepsy Advocacy Europe Task Force. Epilepsia, (E-pub ahead of print).
- Blumenfeld H., Klein J.P., Schridde U., Vestal M., Rice T., Khera D.S. et al.:Early treatment suppresses the development of spike-wave epilepsy in a rat model. Epilepsia, 2008, 49: 400–409.
- Chapman K.E., Specchio N., Shinnar S., Holmes G.L.:Seizing control of epileptic activity can improve outcome. Epilepsia (E-pub ahead of print).
- Jozwiak S., Kotulska K., Domanska-Pakiela D., Lojszczyk B., Syczewska M., Chmielewski D. et al.:Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex. Eur. J. Paediatr. Neurol., 2011, 15: 424–431.
- Moshe S.L., Perucca E., Ryvlin P., Tomson T.:
Epilepsy: new advances . Lancet, 2015, 385: 884–898. - Pitkanen A., Engel J.:Past and present definitions of epileptogen-esis and its biomarkers. Neurotherapeutics, 2014, 11: 231–241.
- Ville D., Enjolras O., Chiron C., Dulac O.:Prophylactic antiepileptic treatment in Sturge-Weber disease. Seizure, 2002, 11: 145–150.
- Yan H.D., Ji-qun C., Ishihara K., Naqayama T., Serikawa T., Sasa M.:Separation of antiepileptogenic and antiseizure effects of levetiracetam in the spontaneously epileptic rat (SER). Epilepsia, 2005, 46: 1170–1177.